Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection
Clinical trial NCT00464893 · COMPLETED
Trial details
- NCT number
- NCT00464893
- Sponsor
- Neovii Biotech
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-01
- Primary completion
- 2009-04-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.